As the aging International Space Station approaches retirement, biotech firms and drugmakers are signing deals with commercial space stations to continue drug research in zero gravity. Nancy Lapid reports ▻ ↧ Drugmakers prepare for next phase of space pharmaceuticals as ISS r... As the International Space Station nears the end of ​its operational life, drugmakers are laying the groundwork for commercial pharmaceutical research and manufacturing in low Earth orbit, while working with regulators to establish rules for ‌producing medicines in space.